Dr. Connie Yang, BC Children’s Hospital, Vancouver, BC

This presentation will discuss current controversies in the management of asthma in children including the use of short courses of inhaled corticosteroids (ICS), as needed use of ICS-formoterol and as needed use of ICS-short acting beta agonists.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Understand the evidence and rationale for the as needed use of ICS-formoterol in children over 12 years of age;
  • Understand the evidence and rationale for the recommendation against the use of short course very high dose ICS in children under 6 years of age; and
  • Understand the evidence and rationale for the recommendation against the as needed use of ICS-short acting beta agonist in children.

CanMEDs Competencies addressed:
Communicator, Leader, Medical Expert, Scholar